INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,712 | -46.1% | 35,250 | -38.2% | 0.00% | – |
| Q2 2023 | $25,452 | -91.5% | 57,004 | -84.4% | 0.00% | – |
| Q1 2023 | $298,910 | -37.2% | 364,524 | +19.6% | 0.00% | -100.0% |
| Q4 2022 | $475,595 | +21.0% | 304,869 | +33.8% | 0.00% | – |
| Q3 2022 | $393,000 | +1.3% | 227,816 | +1.7% | 0.00% | – |
| Q2 2022 | $388,000 | -67.9% | 224,106 | -33.5% | 0.00% | -100.0% |
| Q1 2022 | $1,209,000 | -26.9% | 336,901 | +1.7% | 0.00% | 0.0% |
| Q4 2021 | $1,654,000 | -27.6% | 331,347 | +3.8% | 0.00% | 0.0% |
| Q3 2021 | $2,284,000 | -59.5% | 319,154 | -47.5% | 0.00% | -66.7% |
| Q2 2021 | $5,634,000 | +10.9% | 607,749 | +11.0% | 0.00% | +50.0% |
| Q1 2021 | $5,080,000 | +25.1% | 547,291 | +19.2% | 0.00% | 0.0% |
| Q4 2020 | $4,062,000 | +6.5% | 458,986 | +39.6% | 0.00% | 0.0% |
| Q3 2020 | $3,815,000 | -62.9% | 328,847 | -13.8% | 0.00% | -71.4% |
| Q2 2020 | $10,281,000 | +3044.0% | 381,488 | +769.3% | 0.01% | – |
| Q1 2020 | $327,000 | +109.6% | 43,882 | -6.6% | 0.00% | – |
| Q4 2019 | $156,000 | -10.3% | 46,982 | -44.5% | 0.00% | – |
| Q3 2019 | $174,000 | -4.4% | 84,639 | +36.3% | 0.00% | – |
| Q2 2019 | $182,000 | -18.4% | 62,117 | +4.2% | 0.00% | – |
| Q1 2019 | $223,000 | +17.4% | 59,590 | +25.2% | 0.00% | – |
| Q4 2018 | $190,000 | -58.6% | 47,613 | -42.3% | 0.00% | – |
| Q3 2018 | $459,000 | +59.4% | 82,573 | +12.2% | 0.00% | – |
| Q2 2018 | $288,000 | -36.7% | 73,595 | -23.8% | 0.00% | – |
| Q1 2018 | $455,000 | +35.0% | 96,578 | +18.8% | 0.00% | – |
| Q4 2017 | $337,000 | -46.7% | 81,307 | -18.5% | 0.00% | -100.0% |
| Q3 2017 | $632,000 | +25.9% | 99,761 | +55.6% | 0.00% | – |
| Q2 2017 | $502,000 | -42.9% | 64,098 | -51.7% | 0.00% | -100.0% |
| Q1 2017 | $879,000 | +98.9% | 132,688 | +108.6% | 0.00% | – |
| Q4 2016 | $442,000 | -42.1% | 63,620 | -22.3% | 0.00% | -100.0% |
| Q3 2016 | $763,000 | -25.2% | 81,925 | -25.8% | 0.00% | 0.0% |
| Q2 2016 | $1,020,000 | +6.2% | 110,341 | +0.1% | 0.00% | 0.0% |
| Q1 2016 | $960,000 | +122.2% | 110,246 | +71.7% | 0.00% | – |
| Q4 2015 | $432,000 | -55.6% | 64,221 | -61.9% | 0.00% | -100.0% |
| Q3 2015 | $974,000 | -19.4% | 168,674 | +14.0% | 0.00% | 0.0% |
| Q2 2015 | $1,208,000 | +220.4% | 148,004 | +220.4% | 0.00% | – |
| Q1 2015 | $377,000 | -65.4% | 46,198 | -61.1% | 0.00% | -100.0% |
| Q4 2014 | $1,091,000 | +10.4% | 118,788 | +18.5% | 0.00% | 0.0% |
| Q3 2014 | $988,000 | +4.1% | 100,215 | +14.2% | 0.00% | 0.0% |
| Q2 2014 | $949,000 | – | 87,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |